TAMPA, Fla. (WFLA) — Tampa General Hospital announced on Tuesday it is participating in a clinical trial for treating urinary incontinence following prostate removal surgery.
Teaming up with the USF Health Morsani College of Medicine to pave the way in urological research, the TGH Urology Institute has enrolled its first patient in the ARID II clinical trial.
The nationwide study will evaluate the Voro Urological Scaffold, which is an investigational device intended to support urinary control in men following prostate removal…